Skip to main content
Top
Published in: BMC Gastroenterology 1/2013

Open Access 01-12-2013 | Research article

Clinical utility and tolerability of JSPH-1 wireless esophageal pH monitoring system

Authors: Jun-Nan Li, Chun-Lun Liu, Xiao-Hong Tao

Published in: BMC Gastroenterology | Issue 1/2013

Login to get access

Abstract

Background

Wireless esophageal pH monitoring system is an important approach for diagnosis of gastroesophageal reflux disease (GERD), the aim of this study is to test the tolerability and utility of the first wireless esophageal pH monitoring system made in China, and evaluate whether it is feasible for clinical application to diagnose GERD.

Methods

Thirty patients from Department of Gastroenterology of The First Affiliated Hospital of Chongqing Medical University who were suspected GERD underwent JSPH-1 pH capsule. The capsule was placed 5 cm proximal to the squamocolumnar junction (SCJ) by endoscopic determination, the data was recorded consecutively for 48 hours. Then all pH data was downloaded to a computer for analysis. The discomforts reported by patients were recorded.

Results

30 patients were placed JSPH-1 pH capsule successfully and completed 24-hour data recording, 29 patients completed 48-hour data recording. One patient complained of chest pain and required endoscopic removal. No complications and interference of daily activities were reported during data monitoring or follow-up period. 48-hour pH monitoring detected 15 patients of abnormal acid exposure, on day1 detected 9 patients, the difference had statistical significance (P<0.01). Positive symptom index (SI) was identified in 3 patients with normal pH data in both 24-hours. In total, 48-hour monitoring increased diagnosis of GERD in 9 patients.

Conclusion

48-hour esophageal pH monitoring with JSPH-1 wireless pH monitoring system is safe, well tolerated and effective. It can be feasible for clinical application to diagnose GERD.
Appendix
Available only for authorised users
Literature
1.
go back to reference Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R: The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterology. 2006, 101: 1900-1920. 10.1111/j.1572-0241.2006.00630.x.CrossRef Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R: The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterology. 2006, 101: 1900-1920. 10.1111/j.1572-0241.2006.00630.x.CrossRef
2.
go back to reference He J, Ma X, Zhao Y, Wang R, Yan XY, Yan H, Yin P, Kang XP, Fang JQ, Hao YT, Li Q, Dent J, Sung JJY, Zou DW, Wallander MA, Johansson S, Liu WB, Li ZS: A population-based survey of the epidemiology of symptom-defined gastroesophageal reflux disease: The Systematic Investigation of Gastrointestinal Diseases in China. BMC Gastroenterol. 2010, 10: 94-10.1186/1471-230X-10-94.CrossRefPubMedPubMedCentral He J, Ma X, Zhao Y, Wang R, Yan XY, Yan H, Yin P, Kang XP, Fang JQ, Hao YT, Li Q, Dent J, Sung JJY, Zou DW, Wallander MA, Johansson S, Liu WB, Li ZS: A population-based survey of the epidemiology of symptom-defined gastroesophageal reflux disease: The Systematic Investigation of Gastrointestinal Diseases in China. BMC Gastroenterol. 2010, 10: 94-10.1186/1471-230X-10-94.CrossRefPubMedPubMedCentral
3.
go back to reference Ayazi S, Lipham JC, Portale G, Peyre CG, Street CG, Leers JM, Demeester SR, Banki F, Chan LS, Hagen JA, Demeester TR: Bravo Catheter-Free pH Monitoring: Normal Values, Concordance, Optimal Diagnostic Thresholds, and Accuracy. Clin Gastroenterol Hepatol. 2009, 7: 60-67. 10.1016/j.cgh.2008.08.020.CrossRefPubMed Ayazi S, Lipham JC, Portale G, Peyre CG, Street CG, Leers JM, Demeester SR, Banki F, Chan LS, Hagen JA, Demeester TR: Bravo Catheter-Free pH Monitoring: Normal Values, Concordance, Optimal Diagnostic Thresholds, and Accuracy. Clin Gastroenterol Hepatol. 2009, 7: 60-67. 10.1016/j.cgh.2008.08.020.CrossRefPubMed
4.
go back to reference Bhat YM, McGrath KM, Bielefeldt K: Wireless Esophageal pH Monitoring: new technique means new questions. J Clin Gastroenterol. 2006, 40: 116-121. 10.1097/01.mcg.0000196188.57543.75.CrossRefPubMed Bhat YM, McGrath KM, Bielefeldt K: Wireless Esophageal pH Monitoring: new technique means new questions. J Clin Gastroenterol. 2006, 40: 116-121. 10.1097/01.mcg.0000196188.57543.75.CrossRefPubMed
5.
go back to reference Pandolfino JE, Richter JE, Ours T, Guadino JM, Chapman J, Kahrilas PJ: Ambulatory esophageal pH monitoring using a wireless system. Am J Gastroenterol. 2003, 98: 740-749. 10.1111/j.1572-0241.2003.07398.x.CrossRefPubMed Pandolfino JE, Richter JE, Ours T, Guadino JM, Chapman J, Kahrilas PJ: Ambulatory esophageal pH monitoring using a wireless system. Am J Gastroenterol. 2003, 98: 740-749. 10.1111/j.1572-0241.2003.07398.x.CrossRefPubMed
6.
go back to reference Bradley AG, Crowell MD, DiBaise JK, Kim HJ, Burdick GE, Fleischer DE, Sharma VK: Comparison of the Impact of Wireless Versus Catheter-based pH-metry on Daily Activities and Study-related Symptoms. J Clin Gastroenterol. 2011, 45: 100-106. 10.1097/MCG.0b013e3181e5d32a.CrossRefPubMed Bradley AG, Crowell MD, DiBaise JK, Kim HJ, Burdick GE, Fleischer DE, Sharma VK: Comparison of the Impact of Wireless Versus Catheter-based pH-metry on Daily Activities and Study-related Symptoms. J Clin Gastroenterol. 2011, 45: 100-106. 10.1097/MCG.0b013e3181e5d32a.CrossRefPubMed
7.
go back to reference Grigolon A, Bravi I, Conte D, Penagini R, Cant` u P: Wireless pH monitoring: Better tolerability and lower impact on daily habits. Dig Liver Dis. 2007, 39: 720-724. 10.1016/j.dld.2007.05.011.CrossRefPubMed Grigolon A, Bravi I, Conte D, Penagini R, Cant` u P: Wireless pH monitoring: Better tolerability and lower impact on daily habits. Dig Liver Dis. 2007, 39: 720-724. 10.1016/j.dld.2007.05.011.CrossRefPubMed
8.
go back to reference Tseng D, Rizvi AZ, Fennerty MB, Jobe BA, Diggs BS, Sheppard BC, Gross SC, Swanstrom LL, White NB, Aye RW, Hunter JG: Forty-Eight-Hour pH Monitoring Increases Sensitivity in Detecting Abnormal Esophageal Acid Exposure. J Gastrointest Surg. 2005, 9: 1043-1051. 10.1016/j.gassur.2005.07.011.CrossRefPubMed Tseng D, Rizvi AZ, Fennerty MB, Jobe BA, Diggs BS, Sheppard BC, Gross SC, Swanstrom LL, White NB, Aye RW, Hunter JG: Forty-Eight-Hour pH Monitoring Increases Sensitivity in Detecting Abnormal Esophageal Acid Exposure. J Gastrointest Surg. 2005, 9: 1043-1051. 10.1016/j.gassur.2005.07.011.CrossRefPubMed
9.
go back to reference Wenner J, Johnsson F, Johansson J, Oberg S: Wireless oesophageal pH monitoring: feasibility, safety and normal values in healthy subjects. Scand J Gastroenterol. 2005, 40: 768-774.CrossRefPubMed Wenner J, Johnsson F, Johansson J, Oberg S: Wireless oesophageal pH monitoring: feasibility, safety and normal values in healthy subjects. Scand J Gastroenterol. 2005, 40: 768-774.CrossRefPubMed
10.
go back to reference Wenner J, Johnsson F, Johansson J, Oberg S: Wireless esophageal pH monitoring is better tolerated than the catheter-based technique: results from a randomized cross-over trial. Am J Gastroenterol. 2007, 102: 239-245. 10.1111/j.1572-0241.2006.00939.x.CrossRefPubMed Wenner J, Johnsson F, Johansson J, Oberg S: Wireless esophageal pH monitoring is better tolerated than the catheter-based technique: results from a randomized cross-over trial. Am J Gastroenterol. 2007, 102: 239-245. 10.1111/j.1572-0241.2006.00939.x.CrossRefPubMed
11.
go back to reference Lacy BE, Dukowicz AC, Robertson DJ, Weiss JE, Teixeira P, Kelley ML: Clinical Utility of the Wireless pH Capsule. J Clin Gastroenterol. 2011, 45: 429-435. 10.1097/MCG.0b013e3181f3a48c.CrossRefPubMed Lacy BE, Dukowicz AC, Robertson DJ, Weiss JE, Teixeira P, Kelley ML: Clinical Utility of the Wireless pH Capsule. J Clin Gastroenterol. 2011, 45: 429-435. 10.1097/MCG.0b013e3181f3a48c.CrossRefPubMed
12.
go back to reference Wong WM, Bautista J, Dekel R, Malagon IB, Tuchinsky I, Green C, Dickman R, Esquivel R, Fass R: Feasibility and tolerability of transnasal/per-oral placement of the wireless pH capsule vs. traditional 24-h oesophageal pH monitoring—a randomized trial. Aliment Pharmacol Ther. 2005, 21: 155-163. 10.1111/j.1365-2036.2005.02313.x.CrossRefPubMed Wong WM, Bautista J, Dekel R, Malagon IB, Tuchinsky I, Green C, Dickman R, Esquivel R, Fass R: Feasibility and tolerability of transnasal/per-oral placement of the wireless pH capsule vs. traditional 24-h oesophageal pH monitoring—a randomized trial. Aliment Pharmacol Ther. 2005, 21: 155-163. 10.1111/j.1365-2036.2005.02313.x.CrossRefPubMed
13.
go back to reference Johnson LF, DeMeester TR: Development of the 24-hour intraesophageal pH monitoring composite scoring system. J Clin Gastroenterol. 1986, 8: 52-58.CrossRefPubMed Johnson LF, DeMeester TR: Development of the 24-hour intraesophageal pH monitoring composite scoring system. J Clin Gastroenterol. 1986, 8: 52-58.CrossRefPubMed
14.
go back to reference Jamieson JR, Stein HJ, DeMeester TR, Bonavina L, Schwizer W, Hinder RA, Albertucci M: Ambulatory 24-h esophageal pH monitoring: normal values, optimal thresholds, specificity, sensitivity, and reproducibility. Am J Gastroenterol. 1992, 87: 1102-1111.PubMed Jamieson JR, Stein HJ, DeMeester TR, Bonavina L, Schwizer W, Hinder RA, Albertucci M: Ambulatory 24-h esophageal pH monitoring: normal values, optimal thresholds, specificity, sensitivity, and reproducibility. Am J Gastroenterol. 1992, 87: 1102-1111.PubMed
15.
go back to reference Wiener GJ, Richter JE, Copper JB, Wu WC, Castell DO: The symptom index: a clinically important parameter of ambulatory 24-hour esophageal pH monitoring. Am J Gastroenterol. 1988, 83: 358-361.PubMed Wiener GJ, Richter JE, Copper JB, Wu WC, Castell DO: The symptom index: a clinically important parameter of ambulatory 24-hour esophageal pH monitoring. Am J Gastroenterol. 1988, 83: 358-361.PubMed
16.
go back to reference Budzyński J: Exertional esophageal pH-metry and manometry in recurrent chest pain. World J Gastroenterol. 2010, 16 (34): 4305-4312. 10.3748/wjg.v16.i34.4305.CrossRefPubMedPubMedCentral Budzyński J: Exertional esophageal pH-metry and manometry in recurrent chest pain. World J Gastroenterol. 2010, 16 (34): 4305-4312. 10.3748/wjg.v16.i34.4305.CrossRefPubMedPubMedCentral
17.
go back to reference Grigolon A, Consonni D, Bravi I, Tenca A, Penagini R: Diagnostic yield of 96-h wireless pH monitoring and usefulness in patients’ management. Scand J Gastroenterol. 2011, 46: 522-530. 10.3109/00365521.2010.545834.CrossRefPubMed Grigolon A, Consonni D, Bravi I, Tenca A, Penagini R: Diagnostic yield of 96-h wireless pH monitoring and usefulness in patients’ management. Scand J Gastroenterol. 2011, 46: 522-530. 10.3109/00365521.2010.545834.CrossRefPubMed
18.
go back to reference Sweis R, Fox M, Anggiansah A, Wong T: Prolonged wireless pH-studies have a high diagnostic yield in patients with reflux symptoms and negative 24-h catheter-based pH-studies. Neurogastroenterol Motil. 2011, 23: 419-426. 10.1111/j.1365-2982.2010.01663.x.CrossRefPubMed Sweis R, Fox M, Anggiansah A, Wong T: Prolonged wireless pH-studies have a high diagnostic yield in patients with reflux symptoms and negative 24-h catheter-based pH-studies. Neurogastroenterol Motil. 2011, 23: 419-426. 10.1111/j.1365-2982.2010.01663.x.CrossRefPubMed
19.
go back to reference Domingues GR, Moraes-Filho JP, Domingues AG: Impact of prolonged 48-h wirless capsule esophageal pH monitoring on diagnosis of gastroesophageal reflux disease and evaluation of the relationship between symptom and refluxepisodes. Arq Gastroenterol. 2011, 48: 24-29. 10.1590/S0004-28032011000100006.CrossRefPubMed Domingues GR, Moraes-Filho JP, Domingues AG: Impact of prolonged 48-h wirless capsule esophageal pH monitoring on diagnosis of gastroesophageal reflux disease and evaluation of the relationship between symptom and refluxepisodes. Arq Gastroenterol. 2011, 48: 24-29. 10.1590/S0004-28032011000100006.CrossRefPubMed
20.
go back to reference Pandolfino JE: Bravo capsule pH monitoring. Am J Gastroenterol. 2005, 100: 8-10. 10.1111/j.1572-0241.2005.41183.x.CrossRefPubMed Pandolfino JE: Bravo capsule pH monitoring. Am J Gastroenterol. 2005, 100: 8-10. 10.1111/j.1572-0241.2005.41183.x.CrossRefPubMed
21.
go back to reference Tharavej C, Hagen JA, Portale G, Hsieh CC, Gandamihardja TA, Lipham JC, Peters JH, DeMeester SR, Crookes PF, Bremner CG, DeMeester TR: Bravo capsule induction of esophageal hypercontractility and chest pain. Surg Endosc. 2006, 20: 783-786. 10.1007/s00464-005-0257-8.CrossRefPubMed Tharavej C, Hagen JA, Portale G, Hsieh CC, Gandamihardja TA, Lipham JC, Peters JH, DeMeester SR, Crookes PF, Bremner CG, DeMeester TR: Bravo capsule induction of esophageal hypercontractility and chest pain. Surg Endosc. 2006, 20: 783-786. 10.1007/s00464-005-0257-8.CrossRefPubMed
22.
go back to reference Bechtold ML, Holly JS, Thaler K, Marshall JB: Bravo (wireless) ambulatory esophageal pH monitoring: how do day 1 and day 2 results compare. World J Gastroenterol. 2007, 13: 4091-4095.CrossRefPubMedPubMedCentral Bechtold ML, Holly JS, Thaler K, Marshall JB: Bravo (wireless) ambulatory esophageal pH monitoring: how do day 1 and day 2 results compare. World J Gastroenterol. 2007, 13: 4091-4095.CrossRefPubMedPubMedCentral
23.
go back to reference Prakash C, Clouse RE: Value of extended recording time with wireless pH monitoring in evaluating gastroesophageal. Clin Gastroenterol Hepatol. 2005, 3: 329-334. 10.1016/S1542-3565(05)00021-2.CrossRefPubMed Prakash C, Clouse RE: Value of extended recording time with wireless pH monitoring in evaluating gastroesophageal. Clin Gastroenterol Hepatol. 2005, 3: 329-334. 10.1016/S1542-3565(05)00021-2.CrossRefPubMed
24.
go back to reference Galmiche JP, Clouse RE, Bálint A, Cook IJ, Kahrilas PJ, Paterson WG, Smout AJ: Functional esophageal disorders. Gastroenterology. 2006, 130: 1459-1465. 10.1053/j.gastro.2005.08.060.CrossRefPubMed Galmiche JP, Clouse RE, Bálint A, Cook IJ, Kahrilas PJ, Paterson WG, Smout AJ: Functional esophageal disorders. Gastroenterology. 2006, 130: 1459-1465. 10.1053/j.gastro.2005.08.060.CrossRefPubMed
25.
go back to reference Korrapati V, Babich JP, Balani A, Grendell JH, Kongara KR: Does deep sedation impact the results of 48 hours catheterless pH testing?. World J Gastroenterol. 2011, 17: 1304-1307. 10.3748/wjg.v17.i10.1304.CrossRefPubMedPubMedCentral Korrapati V, Babich JP, Balani A, Grendell JH, Kongara KR: Does deep sedation impact the results of 48 hours catheterless pH testing?. World J Gastroenterol. 2011, 17: 1304-1307. 10.3748/wjg.v17.i10.1304.CrossRefPubMedPubMedCentral
26.
go back to reference Iqbal A, Lee YK, Vitamvas M, Oleynikov D: 48-Hour pH Monitoring Increases the Risk of False PositiveStudies When the Capsule is Prematurely Passed. J GastrointestSurg. 2007, 11: 638-641. 10.1007/s11605-007-0142-y.CrossRef Iqbal A, Lee YK, Vitamvas M, Oleynikov D: 48-Hour pH Monitoring Increases the Risk of False PositiveStudies When the Capsule is Prematurely Passed. J GastrointestSurg. 2007, 11: 638-641. 10.1007/s11605-007-0142-y.CrossRef
27.
go back to reference Pohl D, Tutuian R: Reflux monitoring: pH-metry, bilitec and oesophageal impedance measurements. Best Pract Res Clin Gastroenterol. 2009, 23: 299-311. 10.1016/j.bpg.2009.04.003.CrossRefPubMed Pohl D, Tutuian R: Reflux monitoring: pH-metry, bilitec and oesophageal impedance measurements. Best Pract Res Clin Gastroenterol. 2009, 23: 299-311. 10.1016/j.bpg.2009.04.003.CrossRefPubMed
28.
go back to reference Pritchett JM, Aslam M, Slaughter JC, Ness RM, Garrett CG, Vaezi MF: Efficacy of esophageal impedance/pH monitoring in patients with refractory gastroesophageal reflux disease, on and off therapy. Clin Gastroenterol Hepatol. 2009, 7: 743-748. 10.1016/j.cgh.2009.02.022.CrossRefPubMed Pritchett JM, Aslam M, Slaughter JC, Ness RM, Garrett CG, Vaezi MF: Efficacy of esophageal impedance/pH monitoring in patients with refractory gastroesophageal reflux disease, on and off therapy. Clin Gastroenterol Hepatol. 2009, 7: 743-748. 10.1016/j.cgh.2009.02.022.CrossRefPubMed
Metadata
Title
Clinical utility and tolerability of JSPH-1 wireless esophageal pH monitoring system
Authors
Jun-Nan Li
Chun-Lun Liu
Xiao-Hong Tao
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2013
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/1471-230X-13-10

Other articles of this Issue 1/2013

BMC Gastroenterology 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.